These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5022496)

  • 1. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
    Ropek M; Szymański A; Banaszkiewicz H; Chetkowski A; Czaplińska-Jóźwiak E; Dabrowska-Solecka Z; Ignaczak J; Kondratowicz W; Królikowska H; Pawlik J; Pawlowska I; Sliwińska M; Szuster I; Szymánska W
    Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative controlled trial of rimactane in pulmonary tuberculosis.
    Dormer BA
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):188. PubMed ID: 4895449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term results of treatment with rifampicin in early pulmonary tuberculosis].
    Iodice F
    Arch Monaldi; 1972; 27(1):51-6. PubMed ID: 4568896
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
    Kraan JK; Mulder RJ; van Dijk B
    Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
    Meissner G
    Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
    [No Abstract]   [Full Text] [Related]  

  • 7. Short course treatment with two drugs, isoniazid plus rifampicin for six months: a controlled clinical trial with two treatment regimens.
    Dubra FA
    Bull Int Union Tuberc; 1976; 51(1):61-4. PubMed ID: 1030314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P; Parrot R; Coury C
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [56 recent pulmonary tuberculosis cases treated with combined rifampicin-isoniazid in a controlled experiment].
    Constans P; Morin Y; Saint-Paul M; Bonnaud G; Coury C; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):145-62. PubMed ID: 4916251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Scand J Respir Dis; 1973; 54(2):83-91. PubMed ID: 4122479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].
    Constans P; Morin Y; Coury C; Bariety M
    Acta Tuberc Pneumol Belg; 1969; 60(3):545-53. PubMed ID: 5371679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
    Kreis B; Israël L; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R; Garcia-Besada JA; Castellano A
    Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin in tuberculosis. Summary of the observations and discussion].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):487-96. PubMed ID: 5309062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.